Crohn’s and Depression: If it isn’t one end it’s the other June 15, 2012 — Receiving a diagnosis of any illness can knock the wind out of us. It takes a while to breath normally again. We may experience symptoms of depression while we adjust to the chronic diagnosis and learn to manage it. After […]
Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in Adults With Moderately to Severely Active Ulcerative Colitis First Presentation of Phase 3 Data Shows Significant Improvements in Clinical Remission, Mucosal Healing and Quality of Life Measures after SIMPONI Induction Treatment New study findings show that subcutaneous induction regimens of the anti-tumor necrosis […]
Crohn’s Colitis Flare-Ups May Be Associated With Air Travel FRIDAY, May 25 (IDEAS) Individuals with inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, could possibly be at greater probability for flare-ups whenever they take a flight or go to high altitudes for rock climbing or hiking, new research advises. This additional complications impacted individuals […]
Genetic epidemiology and pharmacogenetics in irritable bowel syndrome first objective is to evaluate the evidence supporting a role for genetics in irritable bowel syndrome .
Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn’s Disease Limited Inflammation In Ulcerative Colitis, the inflammation is limited to the large intestine, which includes the rectum. The rest of the gastrointestinal tract is not involved. Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn’s Disease This study is currently recruiting participants. Verified June 2011 by Haukeland […]
Trial of Growth Hormone Therapy in Pediatric Crohn’s Disease This study has been completed. First Received on April 28, 2005. Last Updated on October 10, 2011 History of Changes Sponsor: Collaborator: Genentech Information provided by (Responsible Party): Children’s Hospital Medical Center, Cincinnati ClinicalTrials.gov Identifier: NCT00109473 Purpose The purpose of this study […]
Safety Announcement Concerning TNF Blockers, FDA is informing the public that it continues to receive reports of a rare cancer of white blood cells (known as Hepatosplenic T-Cell Lymphoma
Clinical trials can be a great opportunity for patients. While participating in the search for cures and effective treatments, you have the chance to access potentially life-changing medications. To participate, patients must meet the specific criteria, understand the risks, and of course, speak with their doctor. Clinical Trials ClinicalTrials.gov provides regularly updated information about federally […]
FDA Approved Biological Therapies FDA Approved Biological Therapies individuals with active Crohn’s disease or ulcerative colitis who may have been unsuccessful on the first- and second-line therapies or that happen to be depending on corticosteroids, researchers report.